The venture capitalist has to decide whether to invest in a medical technology company that licenses intellectual property from a private holding company based IP technology platform. Entrepreneurs Amar Sonia and Fred Khosravi founded Incept LLC commercialize their multifunctional hydrogel technology. The pair then separated Confluent Surgical to develop some, but not all, IP Incept author. The specifics of which will develop IP Confluent been described license agreement between Incept and Confluent. Venture capitalist Charles Guard Schroder Ventures Life Sciences was deciding whether to invest in Series A financing round in Confluent. Initially very excited about the deal, Warden is concerned evaluation Confluent and his ability to succeed in business when he learns about the restrictions for Confluent under license. The case describes the business model Incept and its approach to risk management in early stage companies. The case also addresses issues such as diversification and saving options, and the importance of trust and long-term relationships in the process of decision-making in the business areas.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Bhaskar Chakravorti, Toby Stewart, James Weber Source: Harvard Business School 16 pages. Publication Date: March 25, 2009. Prod. #: 809062-PDF-ENG
Related Case Solutions & Analyses:
ttools (B): The Value of a Patent to the Entrepreneur
DuPont Tyvek(R): Commercializing a Disruptive Innovation
Western-Southern Enterprise
Clemens Family Corp. (A): The Struggle from Family-First to Business-First
Shock to the System: The Galante and Read Merger (A)
CDW Corp. 2002
Singapore TradeNet: Beyond TradeNet to the Intelligent Island
Texas Eastman Co.
Grosvenor Park
ACC Reading No.5: The Statement of Cash Flows
